Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 21.2% on Thursday . The company traded as high as C$0.21 and last traded at C$0.20. Approximately 283,894 shares were traded during trading, a decline of 47% from the average daily volume of 537,850 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The stock has a market cap of C$27.89 million, a PE ratio of -20.00 and a beta of 0.32. The stock has a fifty day moving average of C$0.10 and a 200-day moving average of C$0.07. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Short Nasdaq: An Easy-to-Follow Guide
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What is the S&P/TSX Index?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How to Read Stock Charts for Beginners
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
